These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10959690)

  • 1. Plasma concentration of von Willebrand factor in acute myocardial infarction.
    Sakai H; Goto S; Kim JY; Aoki N; Abe S; Ichikawa N; Yoshida M; Nagaoka Y; Handa S
    Thromb Haemost; 2000 Aug; 84(2):204-9. PubMed ID: 10959690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
    Spiel AO; Gilbert JC; Jilma B
    Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Von Willebrand factor in coronary disease].
    Soskin P; Wiesel ML; Mossard JM; Arbogast R; Najib K; Grunebaum L; Sacrez A; Cazenave JP
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1):85-93. PubMed ID: 7811156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
    Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
    Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction.
    Yamashita A; Sumi T; Goto S; Hoshiba Y; Nishihira K; Kawamoto R; Hatakeyama K; Date H; Imamura T; Ogawa H; Asada Y
    Am J Cardiol; 2006 Jan; 97(1):26-8. PubMed ID: 16377278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
    Lin GQ; Jiang HH; Li YQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble cell adhesion molecules in patients with acute coronary syndrome.
    Xie Y; Zhou T; Shen W; Lu G; Yin T; Gong L
    Chin Med J (Engl); 2000 Mar; 113(3):286-8. PubMed ID: 11775266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
    Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
    Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between inflammation and thrombosis in acute coronary syndrome.
    Lytvyn OI; Kopitsa MP; Petyunina OV
    Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty.
    Asakawa H; Nishikimi T; Suzuki T; Hara S; Tsubokou Y; Yagi H; Yabe A; Tsuchiya N; Horinaka S; Kangawa K; Matsuoka H
    Clin Sci (Lond); 2001 Jan; 100(1):117-26. PubMed ID: 11115426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO blood types: influence on infarct size, procedural characteristics and prognosis.
    Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
    Thromb Res; 2008; 123(2):200-5. PubMed ID: 18378281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Wasilewski J; Osadnik T; Poloński L
    Kardiol Pol; 2006 Sep; 64(9):967-72; discussion 973-4. PubMed ID: 17054028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction.
    Thögersen AM; Jansson JH; Wester PO
    Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?
    Schäfer U; Kurz T; Jain D; Hartmann F; Dendorfer A; Tölg R; Raasch W; Dominiak P; Katus H; Richardt G
    Basic Res Cardiol; 2002 Sep; 97(5):399-408. PubMed ID: 12200640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
    Ray KK; Morrow DA; Gibson CM; Murphy S; Antman EM; Braunwald E
    Eur Heart J; 2005 Mar; 26(5):440-6. PubMed ID: 15673542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent.
    Loubeyre C; Lefèvre T; Louvard Y; Dumas P; Piéchaud JF; Lanore JJ; Angellier JF; Le Tarnec JY; Karrillon G; Margenet A; Pougès C; Morice MC
    Eur Heart J; 2001 Jul; 22(13):1128-35. PubMed ID: 11428853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty.
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Nov; 42(5):195-200. PubMed ID: 14658407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K; Kimura K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Nemoto T; Yamanaka O; Yoshii Y; Tochikubo O; Umemura S
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.